A sustainable business model based on innovation and ... - Roche
A sustainable business model based on innovation and ... - Roche
A sustainable business model based on innovation and ... - Roche
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Oncology franchise approaches CHF 20 billi<strong>on</strong> in sales<br />
Oncology sales<br />
(CHF billi<strong>on</strong>)<br />
20.0<br />
16.0<br />
12.0<br />
8.0<br />
4.0<br />
local growth<br />
+15 %<br />
7%<br />
40%<br />
53%<br />
+27 %<br />
+9 %<br />
+20 %<br />
Double-digit growth c<strong>on</strong>tinues<br />
Europe/RoW<br />
• C<strong>on</strong>tinued str<strong>on</strong>g increase in Avastin sales,<br />
driven by str<strong>on</strong>g uptake in mCRC <strong>and</strong> mBC<br />
• Emerging markets c<strong>on</strong>tributing to<br />
c<strong>on</strong>tinued growth of MabThera, Herceptin<br />
<strong>and</strong> Tarceva<br />
Japan<br />
• Str<strong>on</strong>g launches of Avastin, Tarceva, <strong>and</strong><br />
adjuvant Herceptin<br />
0.0<br />
2004 2005 2006 2007 2008<br />
Europe/RoW US Japan<br />
18
Change language